Eugene Chen
Registered Foreign Lawyer
Hong Kong
Eugene Chen
Registered Foreign Lawyer
Hong Kong
Contact Details
For nearly twenty five years, Eugene has helped clients navigate their most complex disputes in some of the thorniest parts of the world. As a U.S.-trained litigator based in Hong Kong, he helps clients proactively overcome the commercial and regulatory challenges they face when doing business in Asia.
Expertise
Practices
Corporate Governance and Compliance
Investigations, Enforcement and Business Crime
Sectors
Qualifications
Professional
Admitted to practice in California, 1999
Admitted to practice in Washington D.C., 2000
Academic
Bachelor of Arts, summa cum laude, Columbia University, 1995
Juris Doctor, Stanford University, 1998
Related articles
Publications: 17 March 2022
Webinar recordings: International sanctions – what next?
Updated 1 April 2022: Sanctions remain at the top of the agenda following Russia's invasion of Ukraine.
Publications: 02 March 2022
Webinar: International sanctions update on Russia - March 2, 2022
Publications: 28 February 2022
Greater China Risk Insight: Looking ahead in the Year of the Tiger
Expertise
Practices
Corporate Governance and Compliance
Investigations, Enforcement and Business Crime
Sectors
Qualifications
Professional
Admitted to practice in California, 1999
Admitted to practice in Washington D.C., 2000
Academic
Bachelor of Arts, summa cum laude, Columbia University, 1995
Juris Doctor, Stanford University, 1998
Other noteworthy experience
Advising:
- A global bank on impact of the Hong Kong National Security Law, and ways to mitigate risks. Our advice, drawing from our Hong Kong SAR, Mainland China, US, UK practices, features: Impact on the bank's AML/CTF regime; Interactions with existing and newly introduced foreign sanctions regime; Enhanced investigation powers; Data and managing client.
- Four US companies in the apparel, information technology, pharmaceutical, and information and data industries, respectively, regarding corruption and bribery issues before the US Department of Justice and US Securities Exchange Commission.
- A Chinese technology company regarding sanctions issues before the US Bureau of Industry & Security Office of Export Enforcement.
- Various US and European pharmaceutical companies on commercial bribery investigations by Chinese authorities.
- A US consumer product company on an investigation by the Hong Kong Independent Commission Against Corruption.
- Several world leading medical device and pharmaceutical companies on conducting internal audits, and preparing codes of conduct and manuals in dealing with sponsorships and donations to hospitals.
- A major US industrial client and a major US pharmaceutical company on benchmarking of compliance policies and procedures against legal and industry standards.
- A leading US investment bank on due diligence for an investment spanning Thailand, Indonesia, the Philippines, and India.
Several US life sciences clients on FCPA due diligence in relation to acquisitions and joint ventures with Chinese companies. - A US information services company on the FCPA aspects of the termination of employees across China resulting from the largest ever Chinese criminal prosecution for violation of China’s data privacy laws, as well as resulting CIETAC/HKIAC arbitrations and labour disputes.
- A major US electronic manufacturer and a European appliances manufacturer on product recall filings and remedial action planning in China.
Includes experience prior to joining A&O
